000830:SZSELuxi Chemical Group Co., Ltd. Analysis
Data as of 2026-07-11 - not real-time
CN¥11.74
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Luxi Chemical is trading at CNY 11.74, far above its DCF‑derived fair value of CNY 2.24, implying a massive valuation gap. The company’s fundamentals are weak – revenue fell 2.4% year‑over‑year, gross margin is under 10%, and debt‑to‑equity sits at a high 60%, while ROE is only 4.8%. Despite a forward PE of 9.1 suggesting cheapness on future earnings, the current PE of 23.96 and low profitability raise doubts about sustainable earnings growth.
Technically the stock is in a bearish regime: price is below the 20‑day SMA (12.63) and the 50‑day SMA (13.57), the MACD histogram is negative, and RSI at 38 hints at limited upside momentum. Volume is trending downward and 30‑day volatility exceeds 50%, while the beta of –0.19 indicates the stock moves opposite to the market, adding to price instability. Support at CNY 11.37 is narrow and the recent max drawdown of 43% underscores the downside risk.
Given the overvaluation, weak cash generation, high leverage, and bearish technical signals, the outlook remains cautious. The dividend yield of 1.7% is modest, but a payout ratio above 70% coupled with thin free cash flow questions its sustainability. Investors should treat Luxi Chemical as a high‑risk play with limited upside potential unless a clear earnings turnaround materializes.
Technically the stock is in a bearish regime: price is below the 20‑day SMA (12.63) and the 50‑day SMA (13.57), the MACD histogram is negative, and RSI at 38 hints at limited upside momentum. Volume is trending downward and 30‑day volatility exceeds 50%, while the beta of –0.19 indicates the stock moves opposite to the market, adding to price instability. Support at CNY 11.37 is narrow and the recent max drawdown of 43% underscores the downside risk.
Given the overvaluation, weak cash generation, high leverage, and bearish technical signals, the outlook remains cautious. The dividend yield of 1.7% is modest, but a payout ratio above 70% coupled with thin free cash flow questions its sustainability. Investors should treat Luxi Chemical as a high‑risk play with limited upside potential unless a clear earnings turnaround materializes.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish MACD and RSI below 40
- Price below 20‑day SMA and approaching support
- High volatility and decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward PE suggests potential earnings improvement
- Dividend yield offers modest income
- Debt load and thin margins limit upside
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Significant valuation gap to DCF fair value
- Persistently low profitability and negative revenue growth
- High leverage and uncertain dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-2.40%
Profit Margin3.22%
P/E Ratio24.0
ROE4.81%
ROA1.91%
Debt/Equity60.25
P/B Ratio1.2
Op. Cash FlowCN¥3.4B
Free Cash FlowCN¥1.2B
Technical Analysis
TrendBearish
RSI38.5
SupportCN¥11.37
ResistanceCN¥13.76
MA 20CN¥12.63
MA 50CN¥13.57
MA 200CN¥15.43
MACDBearish
VolumeDecreasing
Fear & Greed Index94.59
Valuation
Fair ValueCN¥2.24
Target PriceCN¥20.60
Upside/Downside75.47%
GradeOvervalued
TypeValue
Dividend Yield1.70%
Risk Assessment
Beta-0.19
Volatility51.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.